An observational study in Cardiac Disease, sponsored by Methodist Health System. Recruiting at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-08-04.
Sponsored by Methodist Health System · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 646 studies in Heart Diseases with a site in United States — 93 open to participants now, 131 under way, 5 of them phase 3. Heart Diseases · United States.
Among the 646 studies in Heart Diseases with a site in United States, this one is the 139th largest by planned enrollment of the 206 observational ones that give a count, is one of 30 that started in 2024, is one of 211 observational ones, reaches primary completion later than 43 of the 128 other live ones, and was the 635th registered.
2,135 studies on the registry are indexed under Heart Diseases; 252 are open to participants now.
Browse Heart Diseases studies →93 of the 646 studies in Heart Diseases with a site in United States are open now. Recruiting first, the newest first:
Barbara Ann Karmanos Cancer Institute · Sites in United States
Ages 18+
AnaCardio AB · Sites in United States, Bulgaria, Canada and 5 more countries
Ages 18–85
Abiomed Inc. · Sites in United States
Ages 18–80
Edwards Lifesciences · Sites in United States
Ages 18+
Medtronic Cardiac Ablation Solutions · Sites in United States
Ages 18–85
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 181 Heart Diseases studies recruiting now, 128 (71%) set no upper age limit and 21 (12%) stop at 75 or younger; 32 take children under 18; 42 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
646 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 38 · Phase 2 62 · Phase 3 71 · Phase 4 36
First in 1973; this study’s year is marked. 30 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 350 across 592 observational studies indexed under Heart Diseases.
Median enrollment 161 across the 430 interventional studies, 300 across the 206 observational. Of the 469 that completed or were terminated, 158 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
184 of 646 have an industry lead sponsor. The 10 most frequent:
Methodist Health System is the lead sponsor of 170 studies on the registry; 50 are open to participants now.
Methodist Health System has 2 studies filed under Heart Diseases — fewer than ten, so there is no comparison to draw.
40 of the studies in Heart Diseases with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06077422Phase 3Rutgers, The State University of New JerseyExparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain | 2027-01-11 |
| NCT05153967Vanderbilt University Medical CenterCooperative Assessment of Late Effects for SCD Curative Therapies | 2026-11 |
| NCT06891222Mayo ClinicA Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening | 2026-11 |
| NCT06703489Medtronic Cardiac Ablation SolutionsSafety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS) | 2026-11 |
| NCT02694094Johns Hopkins UniversityImpact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy | 2026-12 |
Add all 40 to your calendar (.ics) → With an account.
Among the 646 studies in Heart Diseases with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to postoperative mortality outcomes for geriatric patients with orthopedic injuries based on Orthopedic Hip Frailty Score and preoperative cardiac clearance predictors.
It is typically a result of advanced aging. Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery. Developed by the Swedish National Quality Registry, the Orthopedic Hip Frailty Score aims to predict short-term postoperative mortality in geriatric patients with hip fractures in order to improve patient outcomes and better allocate resources.
Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
≥60 years old Included in the Methodist Dallas Medical Center Trauma Registry Documented orthopedic injury with surgical management
Exclusion Criteria:
\<60 years old Prisoners, pregnant persons, or other protected populations
This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.
Other: Medical/Phenotype Data Collection Procedures & Data to be Collected
The Methodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality.
Total Number of Study Sites
This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.
Time frame: 5 years
Plan to share: Yes — All information will be blinded in compliance with Good Clinical Practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of protected health information or research information. Only de-identified protected health information will be shared in relevant research mediums.
Supporting information: Study protocol
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Feb 2027, 37 months after the start.
Of 184 non-industry observational studies under Heart Diseases, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 118. This study's planned 37 months is below that.
Counting every sponsor, half of 238 studies reached it within 46 months; a quarter within 18 and three quarters within 95.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.